title: Psychosocial factors and diabetes mellitus: evidence-based treatment guidelines.
abstract: The aim of this project was to develop evidence-based guidelines regarding psychosocial aspects of diabetes mellitus in an effort to help the clinician bridge the gap between research and practice. Recommendations address the following topics: patient education, behavioural medicine, and psychiatric disorders of particular relevance to diabetes: depression, anxiety disorders, eating disorders, and dependence on alcohol and nicotine. The present guidelines were developed through an interdisciplinary process of consensus according to the specifications of evidence-based medicine and are recognized by the German Diabetes Association and the German College for Psychosomatic Medicine as their official guidelines.
authors.affiliation: Department of Psychosomatic Medicine and Psychotherapy, Westfälische Klinik Dortmund/Ruhr-Universität Bochum c/o Schulberg 7, D-65183 Wiesbaden, Germany. mail@dr-frank-petrak.de
authors.forename: Frank
authors.initials: F
authors.lastname: Petrak
authors.forename: Stephan
authors.initials: S
authors.lastname: Herpertz
authors.forename: Christian
authors.initials: C
authors.lastname: Albus
authors.forename: Axel
authors.initials: A
authors.lastname: Hirsch
authors.forename: Bernhard
authors.initials: B
authors.lastname: Kulzer
authors.forename: Johannes
authors.initials: J
authors.lastname: Kruse
mesh_terms: D001364:Awareness; D001519:Behavior; D015190:Blood Glucose Self-Monitoring; D003863:Depression / Q000453:epidemiology / Q000517:prevention & control; D003920:Diabetes Mellitus / Q000097:blood / Q000523:psychology* / Q000534:rehabilitation; D019317:Evidence-Based Medicine / Q000592:standards; D001068:Feeding and Eating Disorders / Q000517:prevention & control / Q000523:psychology; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D010348:Patient Care Team; D010353:Patient Education as Topic; D011584:Psychology / Q000706:statistics & numerical data*
chemical_list: D007004:Hypoglycemic Agents